EVGN

NASDAQ 已收盘

Evogene

0.32 USD
▲+0.00+1.02%
盘后 0.32 +0.66%
2026-11-20
市值
$5.37M
市盈率
—
EPS
-1.26
股息率
—
52 周区间
0.25 – 1.26
成交量
62.77K
Beta
0.67
目标价
—
52W 低 0.2552W 高 1.26
价格走势

公司简介

Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a computational generative AI engine. It also focuses on the development and commercialization of castor bean seeds for industrial uses...